Selected publications
-
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.
Nature Genetics.
2017
Academic Article
GET IT
Times cited: 69 -
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Nature Genetics.
2017
Academic Article
GET IT
Times cited: 66 -
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.
Breast Cancer Research and Treatment.
2017
Academic Article
GET IT
Times cited: 9 -
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women.
Breast Cancer Research.
2016
Academic Article
GET IT
Times cited: 13 -
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Gynecologic Oncology.
2016
Review
GET IT
Times cited: 8 -
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
Nature Genetics.
2016
Review
GET IT
Times cited: 53 -
Assessing associations between the AURKAHMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.
PLoS ONE.
2015
Academic Article
GET IT
Times cited: 11 -
Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers.
Cancer Epidemiology Biomarkers and Prevention.
2015
Academic Article
GET IT
Times cited: 14 -
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Nature Genetics.
2015
Review
GET IT
Times cited: 133 -
DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
PLoS Genetics.
2014
Academic Article
GET IT
Times cited: 22 -
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
Nature Genetics.
2013
Academic Article
GET IT
Times cited: 348 -
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk.
PLoS Genetics.
2013
Academic Article
GET IT
Times cited: 169 -
Breast cancer risk and 6q22.33: Combined results from breast cancer association consortium and consortium of investigators on modifiers of brca1/2.
PLoS ONE.
2012
Academic Article
GET IT
Times cited: 8 -
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.
Human Genetics.
2011
Academic Article
GET IT
Times cited: 12 -
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.
PLoS Biology.
2011
Academic Article
GET IT
Times cited: 52 -
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.
Human Molecular Genetics.
2011
Academic Article
GET IT
Times cited: 54 -
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.
Journal of the National Cancer Institute.
2011
Academic Article
GET IT
Times cited: 31 -
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.
Nature Genetics.
2010
Academic Article
GET IT
Times cited: 234 -
Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.
PLoS Genetics.
2010
Academic Article
GET IT
Times cited: 73 -
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.
Human Molecular Genetics.
2009
Academic Article
GET IT
Times cited: 88